Germany leads the European market in sold production of diagnostic reagents and other pharmaceutical preparations with a value of €1.7182 billion as of 2024. France follows with €0.71111 billion, Italy at €0.40471 billion, and Spain at €0.1156 billion. Denmark, Hungary, Poland, and Czechia contribute smaller amounts, while the Netherlands, Sweden, and Croatia have the lowest values. Year-on-year variations reveal notable growth in Denmark (8.29%) and Hungary (6.02%) during 2023, despite a significant decline in the Netherlands (-64.48%). Germany and Italy experienced steady increases of 2.67% and 2.62%, respectively.
The five-year CAGR reflects moderate to strong growth in most countries, with Denmark and Spain showing the highest growth rates. Future trends may include increased investment in pharmaceutical research and development, particularly in leading nations like Germany and France. Additionally, advancements in biotechnology could spur higher production in Italy and emerging markets within Europe.
Top countries in Sold Production of Diagnostic Reagents and Other Pharmaceutical Preparations by Country
| # | 10 Countries | Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 1,718,200,000 | 2023 | +2.19% | +2.67% | View data |
| 2 | 2 France | 711,110,000 | 2023 | -1.63% | +0.66% | View data |
| 3 | 3 Italy | 404,710,000 | 2023 | +1.1% | +2.62% | View data |
| 4 | 4 Spain | 115,600,000 | 2023 | +7.86% | +5.37% | View data |
| 5 | 5 Denmark | 24,900,000 | 2023 | +0.91% | +8.29% | View data |
| 6 | 6 Hungary | 6,434,100 | 2023 | -1.05% | +6.02% | View data |
| 7 | 7 Poland | 4,863,700 | 2023 | +0.068% | View data | |
| 8 | 8 Czechia | 4,365,400 | 2023 | |||
| 9 | 9 Netherlands | 1,291,700 | 2023 | -0.079% | -64.48% | View data |
| 10 | 10 Sweden | 822,880 | 2023 | +7.67% | View data |
